Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Thorax

• Publication date

  2007-03-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thx.2006.073429PMID 17356056PMCID PMC2094295
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory subtypes in asthma: Assessment and identification using induced sputum

  2006cited by this paper
• IL-4-expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR 3 and CCR 4.

  2005cited by this paper
• Induced sputum inflammatory mediator concentrations in chronic cough.

  2004cited by this paper
• Airway structural alterations selectively associated with severe asthma.

  2003cited by this paper
• Comparison of airway immunopathology of eosinophilic bronchitis and asthma

  2003cited by this paper
• Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis

  2003cited by this paper
• Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma

  2002cited by this paper
• Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

  2002cited by this paper
• Non-eosinophilic asthma: importance and possible mechanisms

  2002cited by this paper
• Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

  2002cited by this paper
• Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids

  2002cited by this paper
• A comparison of the validity of different diagnostic tests in adults with asthma.

  2002cited by this paper
• Mast-cell infiltration of airway smooth muscle in asthma.

  2002cited by this paper
• Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthma

  2002cited by this paper
• Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability.

  2001cited by this paper
• Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8.

  2001cited by this paper
• The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences.

  1999cited by this paper
• Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics.

  1999cited by this paper
• Non-eosinophilic corticosteroid unresponsive asthma.

  1999cited by this paper
• Exhaled and nasal nitric oxide measurements : recommendations

  1997cited by this paper
• Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force.

  1997cited by this paper
• IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity.

  1996cited by this paper
• Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation.

  1995cited by this paper
• Measuring quality of life in asthma.

  1993cited by this paper
• Heterogeneity of Bronchial Asthma

  1981cited by this paper
• [Clinical classification of asthma].

  1968cited by this paper
• A CLINICAL CLASSIFICATION ON ASTHMA BASED UPON A REVIEW OF SIX HUNDRED AND FORTY-EIGHT CASES

  1921cited by this paper

• Exploring the neutrophilic pattern in asthma: are “intermediate” and “high” neutrophilic patients the same population?

  2025cites this paper
• Long Short-term Memory-enhanced Haematology Signal Analysis for Dynamic Eosinophil Activation Profiling in Eosinophilic Otitis Media Diagnosis

  2025cites this paper
• Novel biomarkers in asthma

  2025cites this paper
• Reframing remission in severe asthma: a conceptual framework for distinguishing disease activity versus damage.

  2025cites this paper
• Causes and MEchanisms foR non-atopic Asthma in Children (CAMERA) study: rationale and protocol

  2025cites this paper
• Impact of mepolizumab on airway remodeling and inflammation in severe eosinophilic asthma.

  2025cites this paper
• Enhancing Phenotype Discovery in Electronic Health Records through Prior Knowledge-Guided Unsupervised Learning

  2025cites this paper
• Secretory IgA modifies the association between early-life gut microbiota trajectories and childhood nonatopic wheeze

  2025cites this paper
• Multi-trait genetic analysis of asthma and eosinophils uncovers pleiotropic loci in East Asians

  2025cites this paper
• Diagnosis and treatment options for T2-low asthma.

  2025cites this paper
• Asthma Biologics Across the T2 Spectrum of Inflammation in Severe Asthma: Biomarkers and Mechanism of Action

  2025cites this paper
• IL-17A as a Key Mediator of Pulmonary-Intestinal Immune Interactions in a Mouse Model of Asthma and Colitis

  2025cites this paper
• Type 2 inflammation, a common denominator in chronic airway disease?

  2025cites this paper
• Integration analysis of transcriptomics revealed NETosis heterogeneity and Ncf1 as a prognostic biomarker in neutrophil asthma.

  2025cites this paper
• Depression in children with asthma: Testing a cholinergically mediated “endotype”

  2025cites this paper
• Blood eosinophil-guided systemic corticosteroid duration in adults hospitalised for asthma exacerbation: a randomised, controlled, open-label, non-inferiority trial

  2025cites this paper
• Airway microbiota in young people across four continents differ by country, asthma status and inflammatory phenotype

  2025cites this paper
• Predicting future exacerbations in uncontrolled asthma: a discovery/validation approach using large-scale clinical proteomics.

  2025cites this paper
• Changes in serum periostin levels in uncontrolled asthma in children (DADO phase 2 study).

  2025cites this paper
• Estragole protects against ovalbumin-induced allergic asthma by amelioration of interleukin-4 and interleukin-5 expression in BALB/c mice

  2025cites this paper
• Tapering of inhaled corticosteroids in stable T2-low asthma: a randomized trial of symptom- and biomarker trajectories

  2025cites this paper
• Expert opinion on gray areas in asthma management: A lesson from the innovative project “revolution in asthma” of the Italian thoracic society (AIPO‐ITS)

  2025cites this paper
• The Determinants of Eosinophilia in Patients With Severe Asthma

  2024influential citation
• Real-World Phenotyping and Risk Assessment of Childhood Asthma Burden using National Registries.

  2024cites this paper
• Neutrophil extracellular traps and their implications in airway inflammatory diseases

  2024cites this paper
• Approach to difficult-to-treat asthma in childhood: a narrative review.

  2024cites this paper
• Phenotyping of Severe Asthma in the Era of Broad-acting Anti-asthma Biologics.

  2024cites this paper
• Biomarkers of inflammatory asthma phenotypes

  2024cites this paper
• Asthma bronchiale: Therapie noch detaillierter durch Endotypisierung leiten

  2024cites this paper
• Neutrophilic asthma: current prospects. A review

  2024cites this paper
• Biomarkers in asthma, potential for therapeutic intervention

  2024cites this paper
• Blood Eosinophil Count: Lack of Stability and Association with Wheeze Attacks in Preschool Children.

  2024cites this paper
• Phenotype Characterization and Biomarker Evaluation in Moderate to Severe Type 2-high Asthma

  2024cites this paper
• Metabolic and ionic control of T cells in asthma endotypes.

  2024cites this paper
• Asthma Pathogenesis: Phenotypes, Therapies and Gaps. Summary of the Aspen Lung Conference 2023.

  2024cites this paper
• Biologic Medications for Severe Asthma: Implications for Understanding Pathogenic Heterogeneity and Endotypes

  2024cites this paper
• Identifying Super-Responders: a Review of the Road to Asthma Remission.

  2024cites this paper
• YKL-40 as a possible marker of neutrophilic asthma

  2023influential citation
• Airway Hyperresponsiveness Reflects Corticosteroid-Sensitive Mast Cell Involvement Across Asthma Phenotypes.

  2023cites this paper
• Subsets of Eosinophils in Asthma, a Challenge for Precise Treatment

  2023cites this paper
• HLA-G in asthma and its potential as an effective therapeutic agent.

  2023cites this paper
• Asthma bronchiale: Unterschiedliche Endotypen – unterschiedliche Therapie

  2023cites this paper
• Metabolomics in Animal Models of Bronchial Asthma and Its Translational Importance for Clinics

  2023cites this paper
• Determination of sputum eosinophil count and serum absolute eosinophil count in patients with bronchial asthma and its correlation with disease severity and response to treatment

  2023cites this paper
• The role of IL-13 gene polymorphism in the exacerbation of Asthma severity

  2023cites this paper
• Clinical subtypes of neutrophilic asthma: a cluster analysis from Australasian Severe Asthma Network.

  2023cites this paper
• S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023

  2023cites this paper
• The effects of inhaled corticosteroids on healthy airways

  2023cites this paper
• Biomarker-guided withdrawal of inhaled corticosteroids in asthma patients with a non-T2 inflammatory phenotype – a randomized controlled trial study protocol

  2023cites this paper
• New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis

  2023cites this paper
• Towards a Predict and Prevent Approach in Obstructive Airways Diseases.

  2023cites this paper
• T2-Low Asthma: A Discussed but Still Orphan Disease

  2023cites this paper
• Approach to non-type 2 asthma.

  2023cites this paper
• Airway hyperresponsiveness correlates with airway TSLP in asthma independent of eosinophilic inflammation.

  2023cites this paper
• Cytokine-targeted therapies for asthma and COPD

  2023cites this paper
• Pretreatment Alveolar Nitric Oxide Levels Predict Improvement of Pulmonary Function 1 Year Following Anti-Asthma Treatments in Patients with Inhaled Corticosteroid-Naïve Asthma

  2022cites this paper
• Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways

  2022cites this paper
• Asthma Exacerbations and Glucagon-Like Peptide-1 Receptor Agonists: a Review of the Current Evidence

  2022cites this paper
• Eosinophilic asthma

  2022cites this paper
• Sputum Inflammatory Cells and their Impact on Asthma Control in Adults: A Prospective Study

  2022cites this paper
• Recent insights in the role of biomarkers in severe asthma management

  2022cites this paper
• Identification of key modules and hub genes for eosinophilic asthma by weighted gene co-expression network analysis

  2022cites this paper
• Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study.

  2022cites this paper
• Development and validation of a noninvasive prediction model for identifying eosinophilic asthma.

  2022cites this paper
• Current Understanding of Asthma Pathogenesis and Biomarkers

  2022cites this paper
• Increased mast cell activation in eosinophilic chronic obstructive pulmonary disease

  2022cites this paper
• Reduced bronchodilator reversibility correlates with non-type 2 high asthma and future exacerbations: A prospective cohort study.

  2022cites this paper
• Paucigranulocytic Asthma: Potential Pathogenetic Mechanisms, Clinical Features and Therapeutic Management

  2022cites this paper
• Diagnosis and management of asthma in children

  2022cites this paper
• Investigational approaches for unmet need in severe asthma

  2022cites this paper
• Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker‐high and ‐low severe asthma

  2022cites this paper
• Chronic Allergen Challenge Induces Corticosteroid Insensitivity With Persistent Airway Remodeling and Type 2 Inflammation

  2022cites this paper
• Effects of inhaled corticosteroids (ICS) on lung microbiota and local immune response in long-term treatment of chronic obstructive pulmonary disease (COPD): utility of titration and therapeutic index

  2022cites this paper
• Neutrophils and Asthma

  2022cites this paper
• Current unmet needs and potential solutions to uncontrolled asthma

  2022cites this paper
• Azithromycin to Prevent Recurrent Wheeze Following Severe Respiratory Syncytial Virus Bronchiolitis.

  2022cites this paper
• Heart rate variability as a marker of autonomic nervous system activity in young people with eosinophilic and non-eosinophilic asthma

  2022cites this paper
• Stepped treatment algorithm using budesonide-formoterol for chronic respiratory diseases: A single arm interventional study

  2022cites this paper
• Predictors of Low and High Exhaled Nitric Oxide Values in Asthma: A Real-World Study

  2022cites this paper
• Phenotyping, Precision Medicine, and Asthma.

  2022cites this paper
• Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: a randomized clinical trial.

  2021cites this paper
• Towards Explaining Fixed Airflow Obstruction in Asthma.

  2021cites this paper
• Mast cell tryptases in allergic inflammation and immediate hypersensitivity.

  2021cites this paper
• Inflammatory Profile of Antrochoanal Polyps in the Caucasian Population – A Histologic Study

  2021cites this paper
• Neutrophils in asthma: the good, the bad and the bacteria

  2021cites this paper
• Heterogeneity of paucigranulocytic asthma: A prospective cohort study with hierarchical cluster analysis.

  2021cites this paper
• Corticosteroid insensitivity persists in the absence of STAT1 signaling in severe allergic airway inflammation

  2021cites this paper
• Biomarkers to Predict Response to ICS and LAMA in Adolescents and Adults with Mild Persistent Asthma.

  2021cites this paper
• T helper 17 cells and corticosteroid insensitivity in severe asthma.

  2021cites this paper
• Serum Neutrophil Gelatinase-associated Lipocalin (NGAL) Is Elevated in Patients with Asthma and Airway Obstruction

  2021cites this paper
• Glutamine deficiency shifts the asthmatic state toward neutrophilic airway inflammation

  2021cites this paper
• Oral corticosteroid stewardship for asthma: Time to move from theory to routine clinical practice

  2021cites this paper
• Enhanced airway sensory nerve reactivity in non-eosinophilic asthma

  2021cites this paper
• Oxidative Stress Promotes Corticosteroid Insensitivity in Asthma and COPD

  2021cites this paper
• Weighted gene co-expression network analysis to identify key modules and hub genes associated with paucigranulocytic asthma

  2021cites this paper
• Airway hyperresponsiveness to inhaled mannitol identifies a cluster of non-eosinophilic asthma patients with high symptom burden.

  2021cites this paper
• Performance of fractional exhaled nitric oxide in predicting response to inhaled corticosteroids in chronic cough: a meta-analysis

  2021cites this paper
• The azithromycin to prevent wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population

  2021cites this paper
• Management Strategies to Reduce Exacerbations in non-T2 Asthma.

  2021cites this paper
• Our evolving view of neutrophils in defining the pathology of chronic lung disease

  2021cites this paper